Cargando…

Diabetic Renal Disease

Detalles Bibliográficos
Autores principales:	Fava, Stephen, Hadjadj, Samy, Walker, James
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2014
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3997849/ https://www.ncbi.nlm.nih.gov/pubmed/24808913 http://dx.doi.org/10.1155/2014/598015

Ejemplares similares

Redox Genetic Risk Score and the Incidence of End-Stage Kidney Disease in People with Type 1 Diabetes
por: Mohammedi, Kamel, et al.
Publicado: (2022)

Lower-extremity amputation as a marker for renal and cardiovascular events and mortality in patients with long standing type 1 diabetes
por: Mohammedi, Kamel, et al.
Publicado: (2016)

Diabète et COVID-19 : les leçons de CORONADO
por: Cariou, Bertrand, et al.
Publicado: (2021)

Comment on Chen et al. Clinical Characteristics and Outcomes of Patients With Diabetes and COVID-19 in Association With Glucose-Lowering Medication. Diabetes Care 2020;43:1399–1407
por: Cariou, Bertrand, et al.
Publicado: (2020)

Atherosclerotic cardiovascular disease risk stratification and management in type 2 diabetes: review of recent evidence-based guidelines
por: Gourdy, Pierre, et al.
Publicado: (2023)

Plasma Copeptin and Renal Outcomes in Patients With Type 2 Diabetes and Albuminuria
por: Velho, Gilberto, et al.
Publicado: (2013)

Effects of Lifestyle Modifications and Dietary Habits on Prevention of Diabetes and Cardiovascular Disease
por: McFarlane, Samy I., et al.
Publicado: (2018)

Does nondiabetic renal disease exacerbate diabetic nephropathy in patients with type 2 diabetes?
por: Park, Cheol Whee
Publicado: (2013)

Glucose-lowering treatments and COVID-19 mortality in T2DM
por: Hadjadj, Samy, et al.
Publicado: (2021)

Prognostic Value of Resting Heart Rate on Cardiovascular and Renal Outcomes in Type 2 Diabetic Patients: A competing risk analysis in a prospective cohort
por: Miot, Aurelie, et al.
Publicado: (2012)

Renal transplant outcomes and diabetes
por: Weinrauch, Larry A, et al.
Publicado: (2021)

Euglycaemic ketoacidosis during gestational diabetes with concomitant COVID-19 infection
por: Smati, Sarra, et al.
Publicado: (2021)

COVID-19 and Diabetes Outcomes: Rationale for and Updates from the CORONADO Study
por: Smati, Sarra, et al.
Publicado: (2022)

Tuberin in renal cell hypertrophy
por: Habib, Samy L
Publicado: (2014)

Fetal Exposure to Maternal Type 1 Diabetes Is Associated With Renal Dysfunction at Adult Age
por: Khalil, Charbel Abi, et al.
Publicado: (2010)

Inhaled Corticosteroid Withdrawal in Chronic Obstructive Pulmonary Disease: Can IMPACT Help?
por: Suissa, Samy
Publicado: (2020)

Renal Disease and the Heart
por: Ibrahim, Hassan N.
Publicado: (2022)

The real culprit behind diabetic nephropathy: impaired renal autoregulation?
por: Liu, Ruisheng
Publicado: (2017)

Pathology and Prognosis of Type 2 Diabetes Mellitus with Renal Involvement
por: Cheng, Lu, et al.
Publicado: (2017)

Diabetic Kidney Disease: It Don’t Get No Respect
por: Brunton, Stephen A.
Publicado: (2020)

Variations in Risk of End-Stage Renal Disease and Risk of Mortality in an International Study of Patients With Type 1 Diabetes and Advanced Nephropathy
por: Skupien, Jan, et al.
Publicado: (2019)

Vascular Involvement in Patients with Lower Extremity Artery Disease: Difference of Distribution Pattern among Smoking, Diabetes Mellitus, and End-Stage Renal Disease
por: Ohtake, Takayasu, et al.
Publicado: (2023)

Renal Stem Cells, Tissue Regeneration, and Stem Cell Therapies for Renal Diseases
por: Bussolati, Benedetta, et al.
Publicado: (2015)

Strategies to Reduce the Cost of Renal Complications in Patients With Type 2 Diabetes
por: Gilmer, Todd P., et al.
Publicado: (2011)

Nonalbuminuric Renal Insufficiency: Can It Be a Novel Category of Diabetic Nephropathy?
por: Tanaka, Masami, et al.
Publicado: (2016)

Diabetes and Risk of Renal Cell Carcinoma
por: Habib, Samy L, et al.
Publicado: (2011)

Inflammatory and Fibrotic Mediators in Renal Diseases
por: Rayego-Mateos, Sandra, et al.
Publicado: (2019)

Drug-Metabolizing Enzymes and Metabolic Diseases: Role of Antioxidants
por: Sheweita, Salah A., et al.
Publicado: (2016)

Plasma copeptin, kidney disease, and risk for cardiovascular morbidity and mortality in two cohorts of type 2 diabetes
por: Velho, Gilberto, et al.
Publicado: (2018)

Epicardial adipose tissue deposition in patients with diabetes and renal impairment: Analysis of the literature
por: Kleinaki, Zoi, et al.
Publicado: (2020)

Retinal microvascular alterations related to diabetes assessed by optical coherence tomography angiography: A cross-sectional analysis
por: Gozlan, Julien, et al.
Publicado: (2017)

Microarray profile of human kidney from diabetes, renal cell carcinoma and renal cell carcinoma with diabetes
por: Kosti, Adam, et al.
Publicado: (2015)

Renal Biomarkers and Novel Therapies in Pediatric Nephrology: From Chronic Kidney Disease to Renal Transplantation
por: Chirico, Valeria, et al.
Publicado: (2023)

Editorial for Special Issue—Biomarkers of Renal Disease
por: García-Estañ, Joaquín, et al.
Publicado: (2020)

The spectrum of biopsy-proven renal diseases in Korea
por: Lim, Beom Jin
Publicado: (2020)

Bird on Urinary Deposits,—Frick on Renal Diseases
Publicado: (1852)

Bronzed Skin and Disease of the Supra-renal Capsules
Publicado: (1856)

Special Issue: “Cardiovascular Complications in Renal Diseases”
por: Burlacu, Alexandru, et al.
Publicado: (2023)

Functional annotations of diabetes nephropathy susceptibility loci through analysis of genome-wide renal gene expression in rat models of diabetes mellitus
por: Hu, Yaomin, et al.
Publicado: (2009)

Fiat Lux: illuminating the cell cycle
por: Liccardi, Gianmaria, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_to0n0kd7b2s77grc460v8hp0cp